Search
Search Results
##search.searchResults.foundPlural##
-
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment
2179PDF: 1200HTML: 281 -
LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE
1665PDF: 811HTML: 871jdoe, table 2 infections CML .doc: 205jdoe, table 1 infections CML .doc: 195 -
Guest Editor: G. Castaman GENE THERAPY FOR HEMOPHILIA: FACTS AND QUANDARIES IN THE 21ST CENTURY GENE THERAPY FOR HEMOPHILIA
2156PDF: 1939HTML: 357 -
Parvovirus B19-triggered acute hemolytic anemia and thrombocytopenia in a child with Evans syndrome
3584PDF: 1020HTML: 445Table 1.: 241 -
CRYOGLOBULIN TEST AND CRYOGLOBULINEMIA HEPATITIS C-VIRUS RELATED
4010PDF: 1325HTML: 2288 -
PATIENTS WITH HAEMOGLOBINOPATHIES AND CHRONIC HEPATITIS C: A REALLY DIFFICULT TO TREAT POPULATION IN 2016?
2972PDF: 998HTML: 2068Cover letter: 188 -
SARS-CoV-2 (COVID-19) and Chronic Myeloid Leukemia (CML): a case report and review of ABL kinase involvement in viral infection CML and COVID-19
3326PDF: 1566HTML: 458 -
Antivirals and monoclonal antibody combination therapy in haematological patients in the omicron era Antiviral and monoclonal Antibodies in Haematological Patients in the omicron era
1323PDF: 956HTML: 93 -
A Case of Rupioid Syphilis Masquerading as Aggressive Cutaneous Lymphoma
2386PDF: 1046HTML: 5081Cover Letter: 177Figure 2: 174Figure 1: 183Figure 3: 209Figure 4: 179Figure Legend: 194Table 1: 201Table 2: 194Table 3: 191 -
SIMPLE PERIPHERAL BLOOD SMEAR FINDINGS OF COVID-19 PATIENTS PROVIDE INFORMATION ABOUT THE SEVERITY OF THE DISEASE AND THE DURATION OF HOSPITAL STAY. Peripheral blood smear and COVID-19 severity.
3456PDF: 1191HTML: 458 -
Severe autoimmune hemolytic anemia in Covid-19 infection Autoimmune hemolytic anemia in Covid-19
3309PDF: 1600HTML: 270 -
The ASSOCIATED FACTORS ON CYTOMEGALOVIRUS REACTIVATION OF CRITICALLY ILL IMMUNOCOMPETENT PATIENTS Cytomegalovirus Reactivation of Critically Ill Patients.
134PDF: 137HTML: 9 -
A SEROPREVALENCE OF HBV, HCV AND HIV-1 AND CORRELATION WITH MOLECULAR MARKERS AMONG MULTI-TRANSFUSED THALASSEMIA PATIENTS IN WESTERN INDIA Incidence of serology & molecular of HIV, HBV and HCV in thalassemia patients
1401PDF: 778HTML: 534 -
DISSEMINATED HISTOPLASMOSIS AS AIDS PRESENTATION. CASE REPORT AND COMPREHENSIVE REVIEW OF CURRENT LITERATURE
3765PDF: 1323HTML: 748Figure 2: 465Figure 1: 3144 -
Editorial : INTRODUCING MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
3376PDF: 594HTML: 676 -
APPROACHING THE TARGET: THE PATH TOWARDS AN EFFECTIVE MALARIA VACCINE
2620PDF: 995HTML: 15127 -
Toxic epidermal necrolysis associated with severe cytomegalovirus infection in a patient on regular hemodialysis.
1820PDF: 557HTML: 16986Figure 4: 179Figure 3: 151Figure 2: 157Figure 1: 194 -
TUBERCULOSIS IN HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS.
2690PDF: 973HTML: 3651 -
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT
1371PDF: 1031HTML: 128 -
High level of HBV DNA virus in the breast milk seems not to contraindicate breastfeeding
2234PDF: 836HTML: 961Untitled: 275 -
FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator
2833PDF: 1005HTML: 648 -
DECREASED CD10 EXPRESSION IN THE BONE MARROW NEUTROPHILS OF HIV POSITIVE PATIENTS
1340PDF: 889HTML: 1160Coverletter: 226 -
-
Focusing On A Unique Innate Memory Cell Population Of Natural Killer Cells In The Fight Against COVID-19: Harnessing The Ubiquity Of Cytomegalovirus Exposure Memory Cell Population Of Natural Killer Cells in COVID-19 and Cytomegalovirus Exposure
1250PDF: 941HTML: 294 -
Postpandemic influenza A/H1N1pdm09 is still causing severe perinatal complications
1383PDF: 1006HTML: 2010Cover letter: 207 -
FACTORS PREDICTING MORBIDITY IN PATIENTS WITH DENGUE FEVER IN A TERTIARY CARE HOSPITAL
2476HTML: 9402DOCX: 1026Tables Dengue: 221 -
PATHOBIOLOGY OF HODGKIN LYMPHOMA
3308PDF: 1482HTML: 5959Fig1-Ag-Pil: 244Ag-Pil Fig.2: 245 -
PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID
2721PDF: 964HTML: 563







